SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE ...
Where there is involvement of the tongue, glottis or larynx, likely to cause airway
obstruction, appropriate therapy, which may include subcutaneous epinephrine
solution 1:1000 (0.3 ml to 0.5 ml) and/or measures to ensure a patent airway, s
hould be administered promptly. Black patients receiving ACE inhibitors have
been ...